Furthermore, infants of mothers with SLE who were exposed to anti-Ro/SSA or anti-La/SSB antibodies during pregnancy have shown an increased risk for neonatal lupus syndrome, with its most serious manifestation being fetal heart block [6,9,10]. Here, CALR is linked to neonatal lupus erythematosus.